Mirova US LLC Cuts Position in Xylem Inc. $XYL

Mirova US LLC trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 3.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,933,134 shares of the industrial products company’s stock after selling 67,365 shares during the period. Xylem makes up approximately 2.9% of Mirova US LLC’s holdings, making the stock its 15th largest position. Mirova US LLC owned approximately 0.79% of Xylem worth $285,137,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Maseco LLP purchased a new position in Xylem during the second quarter valued at $31,000. ST Germain D J Co. Inc. raised its position in shares of Xylem by 950.0% in the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 228 shares during the last quarter. Signature Resources Capital Management LLC bought a new position in Xylem in the 2nd quarter worth about $39,000. Caldwell Trust Co purchased a new stake in Xylem during the 2nd quarter valued at about $41,000. Finally, FWL Investment Management LLC purchased a new stake in Xylem during the 2nd quarter valued at about $43,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 0.3%

Shares of Xylem stock opened at $138.42 on Tuesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. The company has a fifty day moving average of $143.03 and a 200 day moving average of $140.02. The company has a market capitalization of $33.70 billion, a P/E ratio of 35.58, a P/E/G ratio of 2.15 and a beta of 1.18. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were given a dividend of $0.40 per share. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Analyst Ratings Changes

Several research analysts have recently issued reports on XYL shares. UBS Group upped their target price on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Stifel Nicolaus boosted their price objective on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Royal Bank Of Canada increased their target price on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Zacks Research cut Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Finally, Robert W. Baird set a $178.00 price objective on Xylem in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average price target of $167.40.

Insider Buying and Selling at Xylem

In other news, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.27% of the stock is currently owned by insiders.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.